Showing 1831-1840 of 2718 results for "".
- BeautyHealth Appoints Bluemercury Founder Marla Beck to Board of Directorshttps://modernaesthetics.com/news/beautyhealth-appoints-bluemercury-founder-marla-beck-to-board-of-directors/2473249/Bluemercury founder Marla Beck is now a member ofThe Beauty Health Company’s Board of Directors. As founder and former CEO of Bluemercury, the disruptive omnichannel beauty retailer founded in 1999 and acquired by Macy’s in 2015, Ms. Beck has a track record of building
- Plastic Surgery Residents Report Barriers to Affordable Childcarehttps://modernaesthetics.com/news/plastic-surgery-residents-report-barriers-to-affordable-childcare/2473246/Plastic surgery residents face persistent barriers accessing affordable childcare, with high costs and a major impact on surgical training—with most of the burden falling on women residents, finds a study in the June issue of Plastic and Reconstructive Surgery. The researchers sen
- Apyx Medical Corporation Scores FDA 510(k) Clearance for Renuvion Handpiecehttps://modernaesthetics.com/news/apyx-medical-corporation-scores-fda-510k-clearance-for-renuvion-handpiece/2473245/The U.S. Food and Drug Administration has granted marketing clearance to Apyx Medical Corporation’s Renuvion Dermal Handpiece for specific dermal resurfacing procedures. The Renuvion Dermal Handpiece is indicated for dermatological procedures for the treatment of moderate to
- Dr. Paul M. Friedman Named New ASLMS Presidenthttps://modernaesthetics.com/news/dr-paul-m-friedman-named-new-aslms-president/2473244/Paul M. Friedman, MD is the new President of the American Society for Laser Medicine and Surgery (ASLMS). Dr. Friedman, board-certified by the American Board of Dermatology, is the director of Dermatology & Laser Surgery Center of Houston
- Colorescience Finishing Touch Protocol Boosts Patient Satisfaction after Microneedling RFhttps://modernaesthetics.com/news/colorescience-finishing-touch-protocol-boosts-patient-satisfaction-after-microneedling-rf/2473243/Colorescience’s Finishing Touch post-treatment skincare protocol improves patient confidence, comfort, satisfaction, and increases the likelihood of a repeat radiofrequency microneedling procedure, according to research in The Journal of Clinical and Aesthetic Dermatology
- Crown Laboratories to Acquire Eclipse Aesthetics Assetshttps://modernaesthetics.com/news/crown-laboratories-to-acquire-eclipse-aesthetics-assets/2473242/Crown Laboratories will acquire the global aesthetics-focused assets of Eclipse. The acquisition expands Crown's aesthetics' product portfolio and enhances Crown's overall value proposition as a global leader in science-based aesthetic skincare solutions.
- Rion Aesthetics Initiates Series Ahttps://modernaesthetics.com/news/rion-aesthetics-initiates-series-a/2473241/With the initiation of Series A funding, Rion Aesthetics presents a unique investment opportunity for aesthetic providers. Rion plans on closing the Series A in the second quarter of 2022. Rion, a regenerati
- Merz Aesthetics Partners with North Carolina Courage, Reigning NWSL Challenge Cup Championshttps://modernaesthetics.com/news/merz-aesthetics-partners-with-north-carolina-courage-reigning-nwsl-challenge-cup-champions/2473240/In a new partnership with the North Carolina Courage, reigning NWSL Challenge Cup Champions and two-time champions of the National Women’s Soccer League (NWSL), Merz Aesthetics aims to promote confidence, character, and sportsmanship. The partnership, kicking off Sunday, includes
- Evolus Celebrates Third Anniversary of the Launch of Jeuveauhttps://modernaesthetics.com/news/evolus-celebrates-third-anniversary-of-the-launch-of-jeuveau/2473239/Evolus, Inc. is celebrating the three-year anniversary of the launch of its flagship neurotoxin product, Jeuveau (prabotulinumtoxinA-xvfs), the first neurotoxin dedicated exclusively to aesthetics. Jeuveau is used for the temporary improvement in the appearance of moderate to severe ve
- Cynosure Receives $60 Million Follow-on Investment from Clayton, Dubilier & Ricehttps://modernaesthetics.com/news/cynosure-recieves-60-million-follow-on-investment-from-clayton-dubilier-rice/2473237/Cynosure, LLC, received $60 million from lead investor Clayton, Dubilier & Rice. The new capital supports the company's plans to continue investing ahead of strong growth to bring innovation to the market and provide comprehensive treatment solutions to its cust